Larissa J. Vos

1.3k total citations
31 papers, 976 citations indexed

About

Larissa J. Vos is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Larissa J. Vos has authored 31 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Larissa J. Vos's work include Microtubule and mitosis dynamics (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Larissa J. Vos is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (4 papers). Larissa J. Vos collaborates with scholars based in Canada, United States and Netherlands. Larissa J. Vos's co-authors include John R. Mackey, Gordon K. Chan, Jakub K. Famulski, Sunita Ghosh, Edith Pituskin, Justin A. Ezekowitz, Sheri L. Koshman, Joseph J. Pagano, Gavin Y. Oudit and Richard B. Thompson and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Larissa J. Vos

31 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larissa J. Vos Canada	16	381	279	276	182	152	31	976
Tejaswitha Jairaj Naik United States	6	561 1.5×	546 2.0×	416 1.5×	158 0.9×	174 1.1×	6	1.4k
Mohsen Ghanefar United States	6	442 1.2×	476 1.7×	267 1.0×	145 0.8×	173 1.1×	8	1.1k
Kamran I. Muhammad United States	15	294 0.8×	334 1.2×	149 0.5×	84 0.5×	152 1.0×	27	824
Rosaria Cammarota Italy	7	285 0.7×	427 1.5×	339 1.2×	102 0.6×	113 0.7×	8	969
Dong Kuang China	20	525 1.4×	72 0.3×	340 1.2×	248 1.4×	187 1.2×	67	1.2k
Priya Bhardwaj United States	16	388 1.0×	96 0.3×	497 1.8×	244 1.3×	86 0.6×	42	1.3k
Wilhelmina Duivenvoorden Canada	20	431 1.1×	80 0.3×	374 1.4×	293 1.6×	401 2.6×	49	1.2k
Hanako Kobayashi United States	19	519 1.4×	68 0.2×	218 0.8×	326 1.8×	94 0.6×	32	1.2k
Gregory J. Aune United States	14	768 2.0×	351 1.3×	470 1.7×	251 1.4×	172 1.1×	24	1.4k
Yujun Li China	17	331 0.9×	77 0.3×	278 1.0×	133 0.7×	239 1.6×	74	831

Countries citing papers authored by Larissa J. Vos

Since Specialization

Citations

This map shows the geographic impact of Larissa J. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa J. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa J. Vos more than expected).

Fields of papers citing papers by Larissa J. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa J. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa J. Vos. The network helps show where Larissa J. Vos may publish in the future.

Co-authorship network of co-authors of Larissa J. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa J. Vos. A scholar is included among the top collaborators of Larissa J. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa J. Vos. Larissa J. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Walker, John, Anil A. Joy, Larissa J. Vos, et al.. (2023). Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis. BMC Medicine. 21(1). 178–178. 10 indexed citations

Joy, Anil A., Larissa J. Vos, Edith Pituskin, et al.. (2021). Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer. Clinical Breast Cancer. 21(5). e584–e593. 3 indexed citations

Patel, Samir, John Amanie, Albert Murtha, et al.. (2021). A Randomized Trial of Short-Course Versus Conventional Radiotherapy With Concomitant and Adjuvant Temozolomide in Patients 18 to 70 Years of Age With Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 111(3). S24–S24. 3 indexed citations

Wang, Michael H., Larissa J. Vos, Don Yee, et al.. (2021). Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer. Practical Radiation Oncology. 11(5). 384–393. 8 indexed citations

Joseph, Kurian, Larissa J. Vos, Zsolt Gabos, et al.. (2020). Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial. Clinical Oncology. 33(1). 30–39. 22 indexed citations

Vos, Larissa J., et al.. (2018). A population-based study examining the influence of a specialized rapid-access cancer clinic on initial treatment choice in localized prostate cancer. Canadian Urological Association Journal. 12(7). E314–7. 2 indexed citations

Mulder, Karen, Christine Brezden‐Masley, Michael M. Vickers, et al.. (2018). A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. Investigational New Drugs. 36(4). 674–682. 1 indexed citations

Pituskin, Edith, John R. Mackey, Sheri L. Koshman, et al.. (2017). Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity. Journal of Clinical Oncology. 35(8). 870–877. 253 indexed citations

Joseph, Kurian, Larissa J. Vos, Heather Warkentin, et al.. (2016). Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer. Radiotherapy and Oncology. 120(2). 228–233. 33 indexed citations

10.

Vos, Larissa J., Keith Wachowicz, John Amanie, et al.. (2016). Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance. World Journal of Radiology. 8(4). 410–410. 11 indexed citations

11.

Joseph, Kurian, Bassam Abdulkarim, Larissa J. Vos, et al.. (2016). 100: A Phase III Randomized Control Trial Comparing Skin Sparing Helical Tomotherapy to 3D-Conformal Radiotherapy for Adjuvant Radiotherapy of Early Stage Breast Cancer. Radiotherapy and Oncology. 120. S39–S39. 1 indexed citations

12.

Lopez-Campistrous, Ana, Matthew G.K. Benesch, Raymond Lai, et al.. (2016). PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer. EBioMedicine. 12. 86–97. 27 indexed citations

13.

Sawyer, Michael B., Edith Pituskin, Sambasivarao Damaraju, et al.. (2015). A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer. Clinical Breast Cancer. 16(2). 139–144.e3. 17 indexed citations

14.

Wuest, Melinda, Sai Kiran Sharma, Susan Richter, et al.. (2015). Targeting lysyl oxidase for molecular imaging in breast cancer. Breast Cancer Research. 17(1). 107–107. 28 indexed citations

15.

Vos, Larissa J., Nasimeh Asgarian, Jean Deschênes, et al.. (2013). A Machine Learned Classifier That Uses Gene Expression Data to Accurately Predict Estrogen Receptor Status. PLoS ONE. 8(12). e82144–e82144. 14 indexed citations

16.

Famulski, Jakub K., Larissa J. Vos, J. B. Rattner, & Gordon K. Chan. (2011). Correction: Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid. PLoS ONE. 6(2). 2 indexed citations

17.

Vos, Larissa J., Jakub K. Famulski, & Gordon K. Chan. (2011). hZwint-1 bridges the inner and outer kinetochore: identification of the kinetochore localization domain and the hZw10-interaction domain. Biochemical Journal. 436(1). 157–168. 13 indexed citations

18.

Famulski, Jakub K., Larissa J. Vos, J. B. Rattner, & Gordon K. Chan. (2011). Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid. PLoS ONE. 6(1). e16494–e16494. 32 indexed citations

19.

Bader, Jason R., Patricia S. Vaughan, Sinji Borges Ferreira Tauhata, et al.. (2011). Zwint-1 is a novel Aurora B substrate required for the assembly of a dynein-binding platform on kinetochores. Molecular Biology of the Cell. 22(18). 3318–3330. 43 indexed citations

20.

Vos, Larissa J., Jakub K. Famulski, & Gordon K. Chan. (2006). How to build a centromere: from centromeric and pericentromeric chromatin to kinetochore assemblyThis paper is one of a selection of papers published in this Special Issue, entitled 27th International West Coast Chromatin and Chromosome Conference, and has undergone the Journal's usual peer review process.. Biochemistry and Cell Biology. 84(4). 619–639. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact